The reversal of the new class of nonvitamin K antagonist oral anticoagulants (NOACs) is challenging in the emergent perioperative setting. This summary focuses on the reversal of NOACs, determining the emergent nature (risk analysis), and other considerations in reversal.
- Nonvitamin K antagonist oral anticoagulants
- Perioperative management
- Reversal agents
ASJC Scopus subject areas